輸入代號或公司名稱後按 Enter
4142

國光生

-0.30 (-1.71%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
17.20769成交張數本益比1.57股價淨值比0.00%殖利率2026-09-11資料日期

毛利率、營業利益率、淨利率

單季;近十年

單季營收

億元

季度營收(億)營收年增毛利(億)毛利率營業利益(億)營業利益率淨利率
2026Q20.7-38.5%-0.6-94.1%-1.7-258.7%-240.0%
2026Q10.814.2%-0.7-90.6%-2.0-242.0%-225.4%
2025Q47.536.8%3.749.6%1.723.1%29.6%
2025Q34.8-46.5%0.817.8%-0.6-13.0%-3.8%
2025Q21.136.1%-0.4-40.6%-2.1-190.3%-201.4%
2025Q10.764.3%-1.2-168.2%-2.6-367.4%-309.6%
2024Q45.5-2.6%1.120.8%-0.8-14.7%-8.9%
2024Q38.9-8.7%4.449.6%2.730.3%29.6%
2024Q20.8-3.3%-0.3-43.9%-2.9-365.9%-343.1%
2024Q10.4-74.2%-0.7-160.3%-2.0-445.3%-419.3%
2023Q45.6-4.3%0.814.5%-3.8-68.6%-74.0%
2023Q39.7-10.5%4.849.8%2.020.4%27.1%
2023Q20.8-84.3%-1.0-115.5%-2.8-337.3%-291.6%
2023Q11.7221.4%-0.6-35.3%-2.6-153.0%-146.7%
2022Q45.8-26.3%2.440.9%0.34.8%10.4%
2022Q310.944.3%5.651.1%3.532.5%38.6%
2022Q25.3498.7%2.140.0%-0.3-6.5%8.6%
2022Q10.5661.9%-1.1-216.8%-2.5-480.7%-444.4%
2021Q47.9-3.5%2.936.1%1.316.1%37.2%
2021Q37.521.9%2.938.9%1.621.0%21.4%
2021Q20.939.5%-0.3-37.6%-2.1-243.7%-185.2%
2021Q10.1-98.1%-0.8-1184.7%-2.8-4009.4%-3604.6%
2020Q48.230.9%3.137.1%0.11.6%151.0%
2020Q36.221.9%2.845.2%1.422.2%26.0%
2020Q20.6-40.1%-0.4-57.4%-1.6-248.5%-226.2%
2020Q13.7509.8%0.820.4%-0.2-5.3%-4.6%
2019Q46.354.3%1.117.6%-0.2-3.4%-3.5%
2019Q35.160.9%2.140.8%1.020.1%21.8%
2019Q21.1245.8%-0.4-42.5%-1.8-170.6%-163.6%
2019Q10.6-14.3%-1.0-174.2%-2.0-331.8%-327.3%
2018Q44.192.4%-2.4-59.4%-3.6-87.6%-85.7%
2018Q33.239.4%0.929.7%-0.3-8.6%-1.9%
2018Q20.3-39.1%-0.6-192.2%-1.5-507.9%-252.8%
2018Q10.7-6.8%-0.9-124.9%-1.8-254.5%-252.8%
2017Q42.1-28.7%-0.8-35.6%-1.8-85.6%-143.6%
2017Q32.346.9%-0.2-8.2%-1.1-47.1%-49.5%
2017Q20.5-55.1%-0.8-159.4%-2.3-462.2%-297.8%
2017Q10.867.3%-0.9-116.3%-1.9-247.8%-259.8%
2016Q43.0-0.8-27.6%-1.9-65.6%-71.9%
2016Q31.5-0.1-6.8%-1.3-82.6%-83.8%